Contribution of somal Lewy bodies to neuronal death

Brain Research

Volumn 775, Issue 1-2, 1997, Pages 24-29

  Tompkins, Margaret M ^a   Hill, William D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Apoptosis; Diffuse Lewy body disease; In situ end labeling; Lewy body; Neurodegeneration; Parkinson's disease; Substantia nigra

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LEWY BODY; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOPTOSIS; FEMALE; HUMANS; LEWY BODIES; MALE; MIDDLE AGED; NEURONS; PARKINSON DISEASE;

EID: 0031474418     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00874-3     Document Type: Article

References (43)

1. P. Anglade, S. Vyas, F. Javoy-Agid et al., Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol. Histopathol., in press.
2. Arends M.J., Morris R.G., Wyllie A.H. Apoptosis. The role of the endonuclease. Am. J. Pathol. 136:1990;593-608.
3. Bergeron C., Petrunka C., Weyer L., Pollanen M.S. Altered neurofilament expression does not contribute to Lewy body formation. Am. J. Pathol. 148:1996;267-272.
4. Buja L.M., Eigenbrodt M.L., Eigenbrodt E.H. Apoptosis and necrosis: basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117:1993;1208-1214.
5. Castellani R.J., Smith M.A., Richey P.L., Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737:1996;195-200.
6. Dexter D.T., Carter C.J., Wells F.R.et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
7. Dragunow M., Faull R.L.M., Lawlor P.et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport. 6:1995;1053-1057.
8. L.S. Forno, The neuropathology of Parkinson's disease, in: F. Hefti, W.J. Weiner (Eds.), Progress in Parkinson Research, Plenum Press, New York, 1988, pp. 11-21.
9. Gai W.P., Blessing W.W., Blumbergs P.C. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain. 118:1995;1447-1459.
10. Gai W.P., Blessing W.W., Blumbergs P.C. Ultrastructure of Lewy neurites in Parkinson's disease and Lewy body dementia. Soc. Neurosci. Abstr. 22:1996;223.
11. Garden G.A., Canady K.S., Lurie D.I., Bothwell M., Rubel E.W. A biphasic change in ribosomal conformation during transneuronal degeneration is altered by inhibition of mitochondrial, but not cytoplasmic protein synthesis. J. Neurosci. 14:1994;1994-2008.
12. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
13. Gertz H.-J., Siegers A., Kuchinke J. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease. Brain Res. 637:1994;339-341.
14. Gibb W.R.G., Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 54:1991;388-396.
15. Hill W.D. Correspondence. Am. J. Pathol. 149:1996;728-729.
16. Hill W.D., Arai M., Cohen J.A., Trojanowski J.Q. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. J. Comp. Neurol. 329:1993;1-9.
17. Hill W.D., Lee V.M.-Y., Hurtig H.I., Murray J.M., Trojanowski J.Q. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies. J. Comp. Neurol. 309:1991;150-160.
18. Hyde G.E., Durham D. Increased deafferentation-induced cell death in chick brainstem auditory neurons following blockade of mitochondrial protein synthesis with chloramphenicol. J. Neurosci. 14:1994;291-300.
19. Iwatsubo T., Yamaguchi H., Fujimuro M.et al. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148:1996;1517-1529.
20. Javoy-Agid F., Hirsch E.C., Dumas S., Duckaerts C., Mallet J., Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopaminergic neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience. 38:1990;245-253.
21. Jenner P., Dexter D.T., Sian J., Schapira A.H.V., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32:1992;S82-S87.
22. Kastner A., Hirsch E.C., Herrero M.T., Javoy-Agid F., Agid Y. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease. J. Neurochem. 61:1993;1024-1034.
23. Lassmann H., Bancher C., Breitschopf H.et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
24. Lee V.M.-Y., Balin B.J., Otvos J.L., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251:1991;675-678.
25. Leigh P.N., Probst A., Dale G.E.et al. New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol. 79:1989;61-72.
26. Migheli A., Cavalla P., Marino S., Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53:1994;606-616.
27. Montine T.J., Farris D.B., Graham D.G. Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J. Neuropathol. Exp. Neurol. 54:1995;311-319.
28. Patt S., Gertz H.-J., Gerhard L., Cervos-Navarro J. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. Histol. Histopathol. 6:1991;373-380.
29. Pollanen M.S., Bergeron C., Weyer L. Detergent-insoluble cortical Lewy body fibrils share epitopes with neurofilament and tau. J. Neurochem. 58:1992;1953-1956.
30. Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52:1993;183-191.
31. Portera-Cailliau C., Hedreen J.C., Price D.L., Koliatsos V.E. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
32. Smale G., Nichols N.R., Brady D.R., Finch C.E., Horton W.E. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:1995;225-230.
33. Swanson P.E. Microwave antigen retrieval in citrate buffer. Lab. Med. 25:1994;520-522.
34. Tompkins M.M., Basgall E.J., Zamrini E., Hill W.D. Apoptotic-like changes in Lewy body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150:1997;119-131.
35. Troncoso J.C., Costello A.C., Kim J.H., Johnson G.V.W. Metal-catalyzed oxidation of bovine neurofilaments in vitro. Free Rad. Biol. Med. 18:1995;891-899.
36. Troost D., Aten J., Morsink F., de Jong J.M.B.V. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol. Appl. Neurobiol. 21:1995;498-504.
37. Wijsman J.H., Jonker R.R., Keijzer R., van de Velde C.J.H., Cornelisse C.J., van Dierendonck J.H. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41:1993;7-12.
38. Wood K.A., Dipasquale B., Youle R.J. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron. 11:1993;621-632.
39. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
40. Yamada T., Akiyama H., McGeer P.L. Two types of spheroid bodies in the nigral neurons in Parkinson's disease. Can. J. Neurol. Sci. 18:1991;287-294.
41. Yamada T., McGeer P.L., McGeer E.G. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol. 84:1992;100-104.
42. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.
43. Yoshiyama Y., Yamada T., Asanuma K., Asahi T. Apoptosis related antigen, Le(y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. 88:1994;207-211.